Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishal J Patel

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Current Molecular Pharmacology|February 13, 2019
Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid HormoneVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Cureus|December 2, 2015
Comparing Radiation Dose from Conventional Fluoroscopy to Intraoperative Cone Beam CT (O-arm) during Percutaneous Lesioning Procedures of the Gasserian GanglionSohum Desai, Vishal J Patel, Rishi R Lall, et al.
Current Research in Pharmacology and Drug Discovery|May 16, 2022
Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive stateAmit A Joharapurkar, Vishal J Patel, Samadhan G Kshirsagar, et al.
Drug Development Research|April 7, 2025
HIF-Prolyl Hydroxylase Inhibitor Desidustat Increases Pyruvate Kinase Activity and Reduces Oxidative Stress in Red Blood Cells, Causes Erythrocytosis in Thalassaemic Mice, and Reduces Sickling in Sickle Cell Patient's BloodVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Inflammopharmacology|November 23, 2024
Inhibition of alternative complement system and prolyl hydroxylase ameliorates anaemia of inflammationVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
International Immunopharmacology|August 31, 2024
Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in miceVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
British Journal of Pharmacology|April 29, 2017
ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitusMukul R Jain, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
World Journal of Diabetes|July 11, 2018
Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitusVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Toxicology and Applied Pharmacology|January 24, 2024
HIF-PHD inhibitor desidustat ameliorates iron deficiency anemiaVishal J Patel, Amit Joharapurkar, Samadhan G Kshirsagar, et al.
Operative Neurosurgery (Hagerstown, Md.)|October 24, 2019
Retrieval of an Intracranially Migrated Dental Injection Needle Through the Foramen Ovale: 2-Dimensional Operative VideoSalah G Aoun, Tarek Y El Ahmadieh, Vin Shen Ban, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Current Molecular Pharmacology|February 13, 2019
Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid HormoneVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Cureus|December 2, 2015
Comparing Radiation Dose from Conventional Fluoroscopy to Intraoperative Cone Beam CT (O-arm) during Percutaneous Lesioning Procedures of the Gasserian GanglionSohum Desai, Vishal J Patel, Rishi R Lall, et al.
Current Research in Pharmacology and Drug Discovery|May 16, 2022
Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive stateAmit A Joharapurkar, Vishal J Patel, Samadhan G Kshirsagar, et al.
Drug Development Research|April 7, 2025
HIF-Prolyl Hydroxylase Inhibitor Desidustat Increases Pyruvate Kinase Activity and Reduces Oxidative Stress in Red Blood Cells, Causes Erythrocytosis in Thalassaemic Mice, and Reduces Sickling in Sickle Cell Patient's BloodVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Inflammopharmacology|November 23, 2024
Inhibition of alternative complement system and prolyl hydroxylase ameliorates anaemia of inflammationVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
International Immunopharmacology|August 31, 2024
Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in miceVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
British Journal of Pharmacology|April 29, 2017
ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitusMukul R Jain, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
World Journal of Diabetes|July 11, 2018
Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitusVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Toxicology and Applied Pharmacology|January 24, 2024
HIF-PHD inhibitor desidustat ameliorates iron deficiency anemiaVishal J Patel, Amit Joharapurkar, Samadhan G Kshirsagar, et al.
Operative Neurosurgery (Hagerstown, Md.)|October 24, 2019
Retrieval of an Intracranially Migrated Dental Injection Needle Through the Foramen Ovale: 2-Dimensional Operative VideoSalah G Aoun, Tarek Y El Ahmadieh, Vin Shen Ban, et al.
Pageof 3